These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Not if but how? Caring for HIV-1 vaccine trial participants in South Africa. Tucker T; Slack C Lancet; 2003 Sep; 362(9388):995. PubMed ID: 14513854 [No Abstract] [Full Text] [Related]
26. Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries. Bourinbaiar AS; Jirathitikal V Curr Pharm Des; 2003; 9(18):1419-31. PubMed ID: 12769722 [TBL] [Abstract][Full Text] [Related]
27. Treatment of HIV infection with cytoreductive agents. Smith C; Lilly S; Miralles GD AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1305-13. PubMed ID: 9788671 [TBL] [Abstract][Full Text] [Related]
29. AIDS 2002: still room for improvement. Sharp M Posit Aware; 2002; 13(1):28-9. PubMed ID: 12216527 [No Abstract] [Full Text] [Related]
30. [HIV infection has become treatable: a medical success that helps only a few]. MMW Fortschr Med; 2006 Oct; 148(42):19. PubMed ID: 17621793 [No Abstract] [Full Text] [Related]
31. The HIV pipeline. Wong A Nat Rev Drug Discov; 2014 Sep; 13(9):649-50. PubMed ID: 25145593 [No Abstract] [Full Text] [Related]
32. [HIV eradication--facts and fiction]. Jaeger H; Wolf E MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923 [No Abstract] [Full Text] [Related]
34. Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy. Peters BS; Samuel M J HIV Ther; 2010 Mar; 15(1):15-7. PubMed ID: 21180234 [No Abstract] [Full Text] [Related]
35. Restoring HIV-specific immunity. James JS AIDS Treat News; 1999 Feb; (No 312):2-6. PubMed ID: 11366200 [TBL] [Abstract][Full Text] [Related]
36. The need for novel targets and approaches to HIV therapy. Martinez LJ Res Initiat Treat Action; 2002; 8(1):23-5. PubMed ID: 12489523 [No Abstract] [Full Text] [Related]
37. [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches]. Manegold C MMW Fortschr Med; 2000 Mar; 142 Suppl 1():34-9. PubMed ID: 10863308 [TBL] [Abstract][Full Text] [Related]
38. Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection. Jones T Curr Opin Investig Drugs; 2010 Aug; 11(8):964-70. PubMed ID: 20721838 [TBL] [Abstract][Full Text] [Related]